RNA, U1 small nuclear 120, pseudogene (RNU1-120P)

RNU1-120P is a pseudogene classified as a non-coding RNA related to the U1 small nuclear RNA (snRNA) gene family[1][2]. U1 snRNAs function as essential components of the spliceosome, mediating pre-mRNA splicing; however, pseudogenes like RNU1-120P do not encode functional proteins or snRNAs, and are generally not translated. Their sequences resemble true snRNA genes but contain mutations or truncations, disrupting their ability to generate mature, functional snRNA[2][3]. Recent research has shown that some snRNA pseudogenes may be transcriptionally active and produce variant snRNAs implicated in the fine-tuning of gene expression, especially in early development or cancer cells[2]. Still, their specific physiological and disease relevance remains largely uncharacterized. This molecule is not classified as a therapeutic target and does not directly interact with drugs; it is mainly of interest in genomics and RNA biology research, especially regarding the regulation of gene expression via non-protein coding mechanisms[2][3]. If detailed, structured mapping or pharmacological targeting is required, RNU1-120P should be excluded or specifically flagged as a non-classical target pseudogene (not a receptor/enzyme/druggable protein).

Other names

RNA, variant U1 small nuclear 22 (RNVU1-22)RNU1-120PRNA, U1 small nuclear 120, pseudogene

Not applicable; no drugs target this pseudogene directly. Antisense oligonucleotides can degrade snRNA/pseudogene-derived transcripts in research settings